Non-Sterile Compounding Pharmacy Market Mega Trends 2018 | By Product - Oral Medication, Topical Medication, Otologic/Nasal Medication and Foreseeing to 2023

Non-Sterile Compounding Pharmacy Market is growing continuously and is expected to grow at a CAGR of 2.65% from 2017 to 2023. Compounding involves the customization of the medicine based on the physician prescription. The pharmacist customizes the dosage or strength and reformulates the drug by excluding unwanted ingredients to which the patient is allergic, or may change the form of the medicine for the patients who are unable to swallow the oral medications.

Non-Sterile Compounding Pharmacy Market: Key players  

Fagron (the Netherlands), B.Braun Melsungen AG (Germany), Fresenius Kabi AG (Germany), TRUE NATURE HOLDING, INC (U.S), Dougherty's Pharmacy Inc. (U.S.), and PHARMEDIUM (U.S.).

Ask for Sample Page @ https://www.marketresearchfuture.com/sample_request/4669 .

Segments:  

The U.S. & Europe non-sterile compounding pharmacy market is segmented into product, application, and end user. By type, the market is segmented into oral medication, topical medication, otologic/nasal medication, and others. The oral medications are further segmented into solid and liquid preparations. The topical medications include ointments, creams, gels, pastes, and others. By application, the market is segmented into pain medication, hormone replacement therapy, and others. By end user, the market is segmented into hospitals, compounding pharmacy, and others.

Non-Sterile Compounding Pharmacy Market: Regional Analysis

America is holding the first position in the market for non-sterile compounding pharmacy owing to the rising demand for customized medicine, increasing prevalence of chronic diseases such as diabetes, and rising number of hospital-based compounding pharmacies. As per the Center for Diseases Control and Prevention (CDC) in 2015, 30.3 million Americans, i.e. 9.4% of the population had diabetes. Additionally, 1.25 million American children and adults had type 1 diabetes.

Europe is the second largest non-sterile compounding pharmacy market across the globe. In Europe, growing awareness about compounding pharmaceutical products for the treatment of chronic diseases such as diabetes, drug allergies, and increasing number of prescriptions for the compounded medications propel the growth of the market. According to the European Academy of Allergy and Clinical Immunology (EAACI), around 2.6% hospitalization happens due to adverse drug effects, while the prevalence of drug allergy in the hospitalized patients is about 10% in the Europe.

Non-Sterile Compounding Pharmacy Market: Market Synopsis

The U.S. Pharmacopeia Convention (USP) formally defines compounding as ‘the preparation, mixing, assembling, altering, packaging, and labelling of a drug, drug-delivery device in accordance with a licensed practitioner's prescription, medication order, or initiative based on the practitioner/patient/ pharmacist/compounder relationship in the course of professional practice.’ Products manufactured by a compounding pharmacy are customized according to the patient need.

Get Discount Page @ https://www.marketresearchfuture.com/check-discount/4669 .

The market for non-sterile compounding pharmacy is driven by an increasing prevalence of chronic diseases such as diabetes, rising need for customized medicine and increasing geriatric population. Furthermore, the demand for anti-aging products that use custom compounded drugs is growing in the U.S. and Europe. However, the strict regulations governing the manufacturing of the compounded product and high prices restrain the market growth. The U.S. & Europe non-sterile compounding pharmacy market is expected to grow steadily at a CAGR of 2.65% during the forecast period.

List of Tables:

Table 1 U.S. & Europe Non-Sterile Compounding Pharmacy Market, By Product,
2014- 2023 (Usd Million) 39
Table 2 U.S. & Europe Non- Sterile Compounding Pharmacy Market For Oral Medications,
By Region, 2014-2023 (Usd Million) 41
Table 3 U.S. & Europe Non- Sterile Compounding Pharmacy Market For Topical Medications,
By Region, 2014-2023 (Usd Million) 42
Table 4 U.S. & Europe Non- Sterile Compounding Pharmacy Market For Otologic/
Nasal Medication, By Region, 2014-2023 (Usd Million) 43
Table 5 U.S. & Europe Non-Sterile Compounding Pharmacy Market, By Application,
2014-2023 (Usd Million) 45
Table 6 U.S. & Europe Non- Sterile Compounding Pharmacy Market, By End User,
2014-2023 (Usd Million) 48
Table 7 U.S. & Europe Non- Sterile Compounding Pharmacy Market, By Region,
2014-2023 (Usd Million) 49
Table 8 U.S. Non- Sterile Compounding Pharmacy Market, By Region, 2014-2023 (Usd Million) 51
Table 9 U.S. Liquid Preparation Market, By Volume, 2014-2023 (Units) 51
Table 10 U.S. Syrups Market, By Volume, 2014-2023 (Units) 51

And more…

List of Figures:

FIGURE 1 U.S. & EUROPE NON-STERILE COMPOUNDING PHARMACY MARKET, BY PRODUCT MARKET SHARE,
FIGURE 2 U.S. & EUROPE NON- STERILE COMPOUNDING PHARMACY MARKET, BY APPLICATION, MARKET SHARE
FIGURE 3 U.S. AND EUROPE NON-STERILE COMPOUNDING PHARMACY MARKET BY END USER, MARKET SHARE
FIGURE 4 MARKET STRUCTURE
FIGURE 5 RESEARCH PROCESS
FIGURE 6 FORECAST MODEL
FIGURE 7 VALUE CHAIN:NON-STERILE COMPOUNDING PHARMACY MARKET
FIGURE 8 PORTERS FIVE FORCES MODEL
FIGURE 9 U.S. & EUROPE NON-STERILE COMPOUNDING PHARMACY MARKET, BY PRODUCT,
2016 & 2023 (USD MILLION)
FIGURE 10 U.S. & EUROPE NON-STERILE COMPOUNDING PHARMACY MARKET, BY APPLICATION,
2014- 2023 (USD MILLION)
FIGURE 11 U.S. & EUROPE NON-STERILE COMPOUNDING PHARMACY MARKET: COMPANY SHARE ANALYSIS
FOR THE KEY PLAYERS, 2016 (%)

Have Any Query, Ask to our Expert @ https://www.marketresearchfuture.com/enquiry/4669 .

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.